We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCACW
3876
CALL
DELISTED
Tuatara Capital Acquisition Corporation Warrant
TCACW
-105,000
Closed -$98K
APSG.WS
3877
CALL
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
-314,388
Closed -$1.78M
CCAC.WS
3878
CALL
DELISTED
CITIC Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary sh
CCAC.WS
-342,872
Closed -$72K
NGCAW
3879
CALL
DELISTED
NextGen Acquisition Corp. II Warrant
NGCAW
-18,029
Closed -$55K
LIII.WS
3880
CALL
DELISTED
Leo Holdings III Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary s
LIII.WS
-270,000
Closed -$767K
VIHAW
3881
CALL
DELISTED
VPC Impact Acquisition Holdings Warrant
VIHAW
-226,508
Closed -$517K
AJAX.WS
3882
CALL
DELISTED
Capri Listco Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exer
AJAX.WS
-400,000
Closed -$184K
TRQ
3883
DELISTED
Turquoise Hill Resources Ltd
TRQ
-22,200
Closed -$655K
MFGP
3884
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
-337,902
Closed -$1.93M
ESTE
3885
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
-181,963
Closed -$2.24M
NLSN
3886
DELISTED
Nielsen Holdings plc
NLSN
-245,719
Closed -$6.81M
IBTX
3887
DELISTED
Independent Bank Group, Inc.
IBTX
-34,192
Closed -$2.1M
EBIX
3888
DELISTED
Ebix Inc
EBIX
-76,274
Closed -$1.45M
MEOA
3889
DELISTED
Minority Equality Opportunities Acquisition Inc. Class A Common Stock
MEOA
-136,103
Closed -$1.38M
SBNY
3890
DELISTED
Signature Bank
SBNY
-19,953
Closed -$3.01M
RACY
3891
DELISTED
Relativity Acquisition Corp. Class A Common Stock
RACY
-370,930
Closed -$3.74M
NTP
3892
DELISTED
Nam Tai Property Inc.
NTP
-124,137
Closed -$231K
MBT
3893
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
-176,535
Closed -$108K
BITE
3894
DELISTED
Bite Acquisition Corp.
BITE
-982,011
Closed -$9.66M
LAC
3895
DELISTED
Lithium Americas Corp. Common Shares
LAC
-72,591
Closed -$1.91M
BHVN
3896
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-19,406
Closed -$2.93M
AGBAW
3897
CALL
DELISTED
AGBA Acquisition Ltd Warrant
AGBAW
-37,464
Closed -$429K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.